Skip to main content
. 2019 Sep 11;14(9):e0221556. doi: 10.1371/journal.pone.0221556

Table 9. Predicted costs and benefits of hypertension management in 2030.

DALYs (000) DALYs in (Billion) TL valued by Savings in DALYs averted (Billion TL) Additional medical costs (Billion TL) Benefit/cost
Column # (1) (2) (3) (4) (5) = (3)/(4)
Real GDP/
capita
Real Gross Income/
Capita
Real GDP/
capita
Real Gross Income/
capita
Status quo 1,561 71.8 92.6 ----- -----
Scenario II 1,169 53.7 69.4 18.0 23.2 2.7 6.7–8.6